Morgentaler ABC, DeWolf WC.: Occult prostate cancer in men with low serum testoster- one levels. JAMA 276:1904-1906, 1996.Morgentaler A, Bruning CO III, DeWolf WC. Occult prostate cancer in men with low serum testosterone levels. JAMA 1996; 276: 1904-6...
They found that men in the group with the lowest levels of testosterone were significantly less likely to develop prostate cancer compared to all other men. Yet interestingly, when men in this group do get prostate cancer, they are 65% more likely to develop an aggressive form of the disease...
"Our goal is to shock thecancer cellsby exposing them rapidly to very high followed by very low levels of testosterone in the blood," explained Prof Denmeade. These alternating extremes in testosterone levels are why the researchers call the therapy "bipolar". Men with declining PSA levels or ...
Zhang PL, Rosen S, Veeramachaneni R, Kao J, DeWolf WC, Bubley G. Association between prostate cancer and serum testosterone levels. Prostate 2002;53:179-82.Zhang PL, Rosen S, Veeramachaneni R, et al. Association between prostate cancer and serum testosterone levels. Prostate 2002;53:179-...
The patients with metastatic prostate cancer with low serum testosterone were in the high risk group of worse response to endocrine therapy. Additional therapy might be considered in those patients. 展开 关键词: prostate cancer testosterone prognosis ...
We studied the association of pretreatment total testosterone levels with the clinical stage and histological grade of prostate cancer. Methods: We evaluated 2914 patients whose pretreatment testosterone levels were recorded from 1982 to 2002. Serum testosterone levels were measured by radioimmunoassay. ...
MarkSoloway. (2009) Low-risk prostate cancer and low testosterone: What are the acceptable alternatives?. Current Urology Reports 10 , 413-417 /Mark, Soloway. (2009) Low-risk prostate cancer and low testosterone: What are the acceptable alternatives?. Current Urology Reports 10 , 413-417 /...
If you’re taking female hormones or testosterone blockers, or had your testicles removed – all of which lower testosterone levels – your risk of prostate cancer is reduced. Most trans women with prostate cancer started hormone treatment after age 50. There is some evidence that transitioning ...
Howard I. Scher, MD, sheds light on various research programs he has led or has been heavily involved with that have helped change the course of prostate cancer treatment over the years.
Hormone therapyis medicine used to decrease testosterone (male hormone) levels. Chemotherapyis medicine used to shrink or kill cancer cells. It is usually given IV. Radiation therapyis used to kill cancer cells with high-energy x-ray beams. You may receive radiation therapy from outside your bo...